GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medx Health MDX.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.05

+12.50%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$473,266

FY2016FY2025

Net income

−C$6.3m

FY2016FY2025

Free cash flow

−C$3.7m

FY2016FY2025

Shareholders' equity

−C$9.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$473,266C$489,698C$456,088C$510,606C$563,101C$530,066C$860,248C$1.1mC$1.1mC$817,055
Gross profitC$147,569C$194,230C$185,628C$239,946C$273,340C$268,106C$479,820C$689,189C$614,491C$437,829
Research and developmentC$499,999C$526,276C$586,084C$681,795C$995,360C$431,163C$535,463C$880,772C$182,461C$182,461
Operating income−C$4.5m−C$2.3m−C$2.4m−C$3.9m−C$4.6m−C$3.0m−C$3.1m−C$4.1m−C$1.5m−C$1.2m
Net income−C$6.3m−C$3.7m−C$4.6m−C$5.1m−C$5.3m−C$3.2m−C$3.3m−C$4.2m−C$1.6m−C$1.3m
Diluted earnings per share-0.02-0.01-0.02-0.03-0.03-0.02-0.02-0.03-0.01-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$702,332C$884,149C$689,614C$718,231C$731,063C$734,390C$435,898C$652,163C$670,978C$798,067
Total liabilitiesC$10.4mC$9.4mC$7.8mC$7.8mC$4.4mC$2.8mC$3.3mC$2.2mC$2.2mC$2.6m
DebtC$253,415C$1.1mC$882,199C$787,614C$2.4mC$232,282—C$534,006C$723,145C$774,540
Shareholders' equity−C$9.7m−C$8.5m−C$7.1m−C$7.1m−C$3.6m−C$2.1m−C$2.9m−C$1.5m−C$1.5m−C$1.8m
Shares outstanding262m262m262m184m184m176m144m135m112m97m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−C$3.7m−C$2.5m−C$3.4m−C$2.8m−C$4.5m−C$2.9m−C$1.3m−C$2.6m−C$1.5m−C$1.3m
Capital spending−C$2,103———−C$16,494−C$5,500−C$4,441−C$10,850−C$1,171−C$3,638
Free cash flow−C$3.7m−C$2.5m−C$3.4m−C$2.8m−C$4.5m−C$2.9m−C$1.3m−C$2.6m−C$1.5m−C$1.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$118,374C$177,749C$138,401C$135,268C$88,512C$111,086C$188,039C$90,609
Gross profitC$43,958C$62,327C$45,042C$37,232C$17,625C$47,670C$73,167C$34,081
Operating income−C$1.2m−C$915,077−C$1.5m−C$878,722−C$931,849−C$1.2m−C$330,080−C$487,051
Net income−C$1.6m−C$1.2m−C$2.1m−C$1.3m−C$1.3m−C$1.6m−C$1.1m−C$693,989
Diluted earnings per share-0.01-0.00-0.01-0.00-0.01-0.01-0.00-0.00
Cash from operations−C$1.0m—−C$1.0m—−C$1.0m———
Total assetsC$485,655C$599,614C$702,332C$1.3mC$991,248C$790,048C$884,149C$875,633
DebtC$1.5mC$1.2mC$253,415C$1.3mC$1.2mC$1.2mC$1.1mC$999,428
Shareholders' equity−C$10.7m−C$9.4m−C$9.7m−C$10.0m−C$8.8m−C$9.5m−C$8.5m−C$9.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.5%-2.2%-8.7%
Operating income5.4%8.4%20.9%
Net income7.0%14.5%28.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin35.5%39.8%43.3%52.1%
Operating margin-709.8%-680.5%-686.5%-389.5%
Net margin-1032.6%-1018.7%-932.3%-485.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-2.5-4.3-3.4-1.4-2.8-6.6-5.7-4.5-7.7-13.8
Price to sales33.232.134.514.426.139.821.717.411.322.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.